DeSantis Expected to Veto Hemp Bill Limiting THC Levels

LOS ANGELES- Florida Governor Ron DeSantis is anticipated to veto Senate Bill 1698, which aims to restrict the sale of hemp-derived products containing delta-8 THC, delta-9 THC, and delta-10 THC. The bill has faced significant opposition from the hemp industry, which argues that it would effectively eliminate hemp businesses in the state.

SB 1698 proposes defining “total delta-9-tetrahydrocannabinol concentration” and setting conditions for the manufacture, distribution, and sale of hemp extract. It also includes provisions to prevent businesses and food establishments from possessing hemp products appealing to children and mandates compliance with state law for hemp products.

Sources indicate that DeSantis, traditionally an opponent of adult-use cannabis, is leaning towards a veto. This decision would align him with the hemp industry, which is in conflict with the broader cannabis industry over THC sources. According to CBS News, this move is seen as strategic, possibly creating an alliance with hemp producers against the recreational cannabis amendment on the November ballot.

The bill’s critics argue that patients and small businesses would be adversely affected. Paige Figi, executive director of the Coalition for Access Now, stated that the legislation would “wipe out” the majority of the CBD health industry in Florida. She emphasized that reducing legal limits of THC would be detrimental to consumers relying on these products for medical relief.

In 2016, Florida voters approved medical cannabis, and the 2018 Farm Bill further expanded the hemp industry by legalizing hemp and its compounds. However, SB 1698’s restrictions threaten this growth. Politicians from both parties have voiced support for the hemp industry, highlighting its importance for patients and small businesses.

As the decision deadline approaches, stakeholders await DeSantis’s final action on the bill, which will significantly impact Florida’s hemp and cannabis landscape.